FDA has continued to exercise its authority, via guidance documents, which FDA says, while not legally enforceable, represent the agencies current thinking on the topic.  To further the judicious use of medically important antimicrobial drugs in animals, the goal of Guidance #263 is to:

(1) Limit medically important antimicrobial drugs to uses in animals that

FDA recently published Guidance #263 titled, “Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntarily Bring Under Veterinary Oversight All Products That Continue to be Available Over-the-Counter,” which builds on earlier provided guidance to limit medically important drugs in food-producing animals. (Guidance #209 and Guidance #213).

As explained in

As reported in the Washington Post on June 19, 2021, the Centers for Disease Control and Prevention has launched a “multistate investigation after imported rescue dog tests positive for rabies variant twice eradicated in U.S.”

This is the fourth case of a dog imported from a country with a high rabies risk later determined

The Fourth edition of the “Guide for the Care and Use of Agricultural Animals in Research and Teaching,” published by the American Dairy Science Association®, American society of Animal Science and Poultry Science Association, is now available on line.

Scientists at a large number of universities contributed to the revisions of the Third edition, resulting

Despite having failed to establish next friends standing in Naruto v. Slater, 2018 WL 1902414 (9th Cir. April 23, 2018), PETA recently filed another case based on next friends standing for alleged animal plaintiffs, 30 barn owls housed at John Hopkins University.  It was entirely predictable that PETA and other animal rights organizations would

As a veterinarian, if a pet-owner comes to you with questions or concerns about the safety of hemp or CBD infused pet products, are you prepared to navigate the conversation?

Practicing veterinarians are subject to the regulation of several entities, both state and federal, including the FDA, the DEA, and their respective state veterinary and

With the passing of the 2018 Farm Bill, the market for cannabis pet products has rapidly grown. As a result, broad-reaching marketing campaigns highlighting the available products and the claimed benefits have become much more prevalent. In response to the prevalence of these campaigns, the FDA and FTC have had to increase efforts to monitor

If you are trying to navigate the space where hemp products intersects with animal products, it can be unclear as to which authority to turn to for guidance. In the United States, FDA, FTC, DEA and USDA share governance over the cannabis and hemp animal product industry, including regulations on labeling, distribution, growing, and sales.

For those who do not receive notifications directly from USDA APHIS, please note that the agency has just announced that it has removed its Self-Reporting Incentive Program, included in the Animal Welfare Act Inspection Guide and published in Tech Note titled, “Incentives for Identifying, Reporting, Correcting, and Preventing Noncompliance with the Animal Welfare Act.”

The